HCK and renal fibrosis: Our recent unbiased screening studies revealed that hematopoietic cell kinase (HCK), a SFK member, promotes renal fibrosis pathway and dasatinib, a non-selective inhibitor of HCK attenuates renal fibrosis in mice with unilateral ureteral obstruction and lupus nephritis14.